QQQ   436.80 (-0.34%)
AAPL   175.15 (-0.79%)
MSFT   420.10 (-0.43%)
META   504.82 (-1.38%)
GOOGL   158.26 (+0.34%)
AMZN   186.16 (+0.02%)
TSLA   165.25 (-3.39%)
NVDA   887.47 (+0.64%)
AMD   161.85 (-0.88%)
NIO   3.90 (-5.11%)
BABA   71.02 (-0.38%)
T   16.32 (+0.06%)
F   12.42 (-1.51%)
MU   123.82 (+1.06%)
GE   154.96 (+0.21%)
CGC   7.44 (-4.62%)
DIS   114.09 (+0.07%)
AMC   2.56 (-3.40%)
PFE   26.04 (+0.70%)
PYPL   64.76 (+0.26%)
XOM   120.67 (+0.25%)
QQQ   436.80 (-0.34%)
AAPL   175.15 (-0.79%)
MSFT   420.10 (-0.43%)
META   504.82 (-1.38%)
GOOGL   158.26 (+0.34%)
AMZN   186.16 (+0.02%)
TSLA   165.25 (-3.39%)
NVDA   887.47 (+0.64%)
AMD   161.85 (-0.88%)
NIO   3.90 (-5.11%)
BABA   71.02 (-0.38%)
T   16.32 (+0.06%)
F   12.42 (-1.51%)
MU   123.82 (+1.06%)
GE   154.96 (+0.21%)
CGC   7.44 (-4.62%)
DIS   114.09 (+0.07%)
AMC   2.56 (-3.40%)
PFE   26.04 (+0.70%)
PYPL   64.76 (+0.26%)
XOM   120.67 (+0.25%)
QQQ   436.80 (-0.34%)
AAPL   175.15 (-0.79%)
MSFT   420.10 (-0.43%)
META   504.82 (-1.38%)
GOOGL   158.26 (+0.34%)
AMZN   186.16 (+0.02%)
TSLA   165.25 (-3.39%)
NVDA   887.47 (+0.64%)
AMD   161.85 (-0.88%)
NIO   3.90 (-5.11%)
BABA   71.02 (-0.38%)
T   16.32 (+0.06%)
F   12.42 (-1.51%)
MU   123.82 (+1.06%)
GE   154.96 (+0.21%)
CGC   7.44 (-4.62%)
DIS   114.09 (+0.07%)
AMC   2.56 (-3.40%)
PFE   26.04 (+0.70%)
PYPL   64.76 (+0.26%)
XOM   120.67 (+0.25%)
QQQ   436.80 (-0.34%)
AAPL   175.15 (-0.79%)
MSFT   420.10 (-0.43%)
META   504.82 (-1.38%)
GOOGL   158.26 (+0.34%)
AMZN   186.16 (+0.02%)
TSLA   165.25 (-3.39%)
NVDA   887.47 (+0.64%)
AMD   161.85 (-0.88%)
NIO   3.90 (-5.11%)
BABA   71.02 (-0.38%)
T   16.32 (+0.06%)
F   12.42 (-1.51%)
MU   123.82 (+1.06%)
GE   154.96 (+0.21%)
CGC   7.44 (-4.62%)
DIS   114.09 (+0.07%)
AMC   2.56 (-3.40%)
PFE   26.04 (+0.70%)
PYPL   64.76 (+0.26%)
XOM   120.67 (+0.25%)

Celularity (CELU) News Today

$4.30
+0.19 (+4.62%)
(As of 12:06 PM ET)
SourceHeadline
globenewswire.com logoCelularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
globenewswire.com - April 15 at 8:00 AM
globenewswire.com logoCelularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells
globenewswire.com - April 8 at 9:00 AM
marketbeat.com logoCelularity Inc. (NASDAQ:CELU) Short Interest Down 16.8% in March
marketbeat.com - March 30 at 3:18 PM
finance.yahoo.com logoCelularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
finance.yahoo.com - March 26 at 9:07 AM
finanznachrichten.de logoCelularity Inc.: Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
finanznachrichten.de - March 20 at 10:49 PM
markets.businessinsider.com logoCelularity Announces Submission Of Request For Orphan Drug Designation For PDA-002
markets.businessinsider.com - March 20 at 10:49 PM
globenewswire.com logoCelularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
globenewswire.com - March 20 at 9:15 AM
finance.yahoo.com logoCELU Apr 2024 10.000 call
finance.yahoo.com - March 16 at 2:14 AM
finance.yahoo.com logoCELU Mar 2024 7.500 put
finance.yahoo.com - March 15 at 11:13 AM
finance.yahoo.com logoCelularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit
finance.yahoo.com - March 14 at 9:48 AM
globenewswire.com logoCelularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit
globenewswire.com - March 14 at 9:15 AM
marketbeat.com logoCelularity Inc. (NASDAQ:CELU) Short Interest Down 87.6% in February
marketbeat.com - March 12 at 12:12 PM
globenewswire.com logoCelularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
globenewswire.com - March 12 at 9:20 AM
edition.cnn.com logoCelularity Inc. Class A
edition.cnn.com - March 8 at 7:15 AM
globenewswire.com logoCelularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells
globenewswire.com - March 7 at 9:35 AM
marketbeat.com logoCelularity Inc. (NASDAQ:CELU) Sees Significant Growth in Short Interest
marketbeat.com - March 4 at 7:41 AM
marketbeat.com logo
marketbeat.com - February 29 at 6:00 AM
finanznachrichten.de logoCelularity, Inc.: Celularity Announces 1-for-10 Reverse Stock Split
finanznachrichten.de - February 24 at 9:51 AM
marketwatch.com logoStocks to Watch: Intuitive Machines, Celularity
marketwatch.com - February 23 at 11:10 PM
markets.businessinsider.com logoCelularity Announce 1-for-10 Reverse Stock Split
markets.businessinsider.com - February 23 at 6:10 PM
marketwatch.com logoCelularity to Effect 1-for-10 Reverse Stock Split
marketwatch.com - February 23 at 6:10 PM
globenewswire.com logoCelularity Announces 1-for-10 Reverse Stock Split
globenewswire.com - February 23 at 4:10 PM
finance.yahoo.com logoCelularity Inc.'s (NASDAQ:CELU) top owners are public companies with 35% stake, while 35% is held by individual investors
finance.yahoo.com - February 22 at 7:06 AM
finance.yahoo.com logoCelularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease
finance.yahoo.com - February 14 at 8:16 PM
globenewswire.com logoCelularity's Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease
globenewswire.com - February 14 at 4:05 PM
benzinga.com logoCelularity Stock (NASDAQ:CELU) Dividends: History, Yield and Dates
benzinga.com - February 6 at 9:35 AM
finance.yahoo.com logoCelularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline
finance.yahoo.com - February 1 at 9:33 AM
finance.yahoo.com logoCelularity and Genting Leaders Comments on Closing $21 Million Financing Transactions
finance.yahoo.com - January 25 at 1:44 PM
finanznachrichten.de logoCelularity, Inc.: Celularity Releases CEO Letter to Shareholders
finanznachrichten.de - January 19 at 9:05 AM
marketwatch.com logoCelularity CEO Says 2023 Revenue to Rise About 23% to 27%
marketwatch.com - January 18 at 2:06 PM
finance.yahoo.com logoCelularity Releases CEO Letter to Shareholders
finance.yahoo.com - January 18 at 2:06 PM
marketwatch.com logoCelularity Gets Commercialization Deal For Oral Healthcare Products
marketwatch.com - January 4 at 4:01 PM
finance.yahoo.com logoCelularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare
finance.yahoo.com - January 4 at 4:01 PM
finanznachrichten.de logoCelularity, Inc.: Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023
finanznachrichten.de - January 3 at 2:01 PM
marketwatch.com logoCelularity Expects 4Q Product, Services Sales to Nearly Triple
marketwatch.com - January 3 at 2:01 PM
msn.com logoCelularity announces fourth-quarter full-year 2023 revenue outlook
msn.com - January 3 at 2:01 PM
finance.yahoo.com logoCelularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023
finance.yahoo.com - January 3 at 2:01 PM
finance.yahoo.com logoCelularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
finance.yahoo.com - December 2 at 8:50 AM
finanznachrichten.de logoCelularity, Inc.: Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
finanznachrichten.de - November 27 at 10:36 AM
msn.com logoCelularity announces receipt of Nasdaq notice regarding late Form 10-Q filing
msn.com - November 24 at 2:31 PM
morningstar.com logoNorth American Morning Briefing: Stock Futures Muted; Nvidia Slips in Offhours Trading
morningstar.com - November 22 at 9:58 AM
finance.yahoo.com logoCelularity Announces Commercial Biomaterial Products Receive Saudi Food and Drug Authority (SFDA) Product Classification
finance.yahoo.com - October 18 at 10:56 AM
finance.yahoo.com logoCelularity Announces Commercial Biomaterial Products Receive Saudi Food and Drug Authority (SFDA) Product Classification
finance.yahoo.com - October 18 at 10:56 AM
finance.yahoo.com logoCelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
finance.yahoo.com - September 7 at 4:55 PM
money.usnews.com logoCelularity Inc - Ordinary Shares - Class A
money.usnews.com - September 1 at 12:59 PM
finanznachrichten.de logoCelularity, Inc.: Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron
finanznachrichten.de - August 29 at 6:18 PM
finance.yahoo.com logoCelularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron
finance.yahoo.com - August 29 at 6:18 PM
finance.yahoo.com logoThis Celularity Insider Increased Their Holding In The Last Year
finance.yahoo.com - August 16 at 11:33 PM
finance.yahoo.com logoCelularity and Verséa Ophthalmics Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3l Ocular For Ophthalmic Applications
finance.yahoo.com - July 27 at 9:24 AM
finance.yahoo.com logoCelularity Inc. Announces $3 Million Registered Direct Offering
finance.yahoo.com - July 27 at 9:24 AM
Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter.

2024 Oil Boom (Ad)

Wall Street’s betting on new oil bull market… JP Morgan analysts have pegged the future price of oil at $380 per barrel. That would send oil companies skyrocketing.

All the details are right here

CELU Media Mentions By Week

CELU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CELU
News Sentiment

0.29

0.65

Average
Medical
News Sentiment

CELU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CELU Articles
This Week

4

1

CELU Articles
Average Week

Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CELU) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners